Chargement en cours...
Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters
BACKGROUND AND PURPOSE: Next to its broad antimicrobial spectrum, the therapeutic advantages of the fluoroquinolone antimicrobial drug Danofloxacin-Mesylate (DM) are attributed to its rapid distribution to the major target tissues such as lungs, intestines and the mammary gland in animals. Previous...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2189727/ https://ncbi.nlm.nih.gov/pubmed/17211460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706974 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|